Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men

2004 ◽  
Vol 42 (10) ◽  
pp. 534-542 ◽  
Author(s):  
A.-R. van Troostenburg ◽  
E.V. Clark ◽  
W.D.H. Carey ◽  
S.J. Warrington ◽  
W.D. Kerns ◽  
...  
Keyword(s):  
Adenosine Receptor ◽  
Receptor Agonist ◽  
Young Men ◽  
Hemodynamic Effects ◽  
Adenosine Receptor Agonist ◽  
A3 Adenosine Receptor

scholarly journals CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver

2011 ◽  
Vol 226 (9) ◽  
pp. 2438-2447 ◽  
Author(s):  
S. Cohen ◽  
S.M. Stemmer ◽  
G. Zozulya ◽  
A. Ochaion ◽  
R. Patoka ◽  
...  
Keyword(s):  
Adenosine Receptor ◽  
Receptor Agonist ◽  
Adenosine Receptor Agonist ◽  
A3 Adenosine Receptor ◽  
Anti Inflammatory

A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway

2017 ◽  
Vol 118 (9) ◽  
pp. 2909-2920 ◽  
Author(s):  
Seyyed Mehdi Jafari ◽  
Mojtaba Panjehpour ◽  
Mahmoud Aghaei ◽  
Hamid Reza Joshaghani ◽  
Seyed Ehsan Enderami
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Adenosine Receptor ◽  
Receptor Agonist ◽  
Breast Cancer Stem Cells ◽  
Adenosine Receptor Agonist ◽  
A3 Adenosine Receptor ◽  
Gli 1
Sign in / Sign up

Export Citation Format

Share Document